EP Patent

EP0908182B1 — Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos)

Assigned to Asubio Pharma Co Ltd · Expires 2003-10-22 · 23y expired

What this patent protects

It is an object of the present invention to provide a therapeutic agent for effectively preventing or ameliorating diseases caused by dysfunction of NOS. The present invention provides a pharmaceutical composition for preventing and/or treating diseases associated with dysfunctio…

USPTO Abstract

It is an object of the present invention to provide a therapeutic agent for effectively preventing or ameliorating diseases caused by dysfunction of NOS. The present invention provides a pharmaceutical composition for preventing and/or treating diseases associated with dysfunction of NOS, comprising as an effective ingredient, a compound of the formula (I): <CHEM> wherein R<1> and R<2> each represents a hydrogen atom or, taken together with each other, represent a single bond, while R<3> represents -CH(OH)CH(OH)CH3, -CH(OCOCH3)CH(OCOCH3)CH3, -CH3, - CH2OH, or a phenyl group when R<1> and R<2> each represents a hydrogen atom, or -COCH(OH)CH3 when R<1> and R<2> together represent a single bond, or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP0908182B1
Jurisdiction
EP
Classification
Expires
2003-10-22
Drug substance claim
No
Drug product claim
No
Assignee
Asubio Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.